Coughlin Timothy bought TVTX
June 12, 2026 · Form 4 insider transaction
Coughlin Timothy bought 10,000 shares of Travere Therapeutics, Inc. at $26.52 per share, a transaction worth $265.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$26.52
Total value
$265.2K
InsiderCoughlin Timothy
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 12, 2026
Filing dateJune 16, 2026
Shares owned after66,250
OwnershipDirect
10b5-1 planNo
AmendedNo